drugset / Trial / NCT00744341
Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the efficacy and safety of IV SLV320 in acute heart failure patients with renal dysfunction.
Timeline
- Start
- 2009-02
- Primary completion
- 2010-01
- Completion
- 2010-01
Outcome
Outcome not reported
Stopped (Business): “This study was stopped 29OCT2009 due to strategic drug development considerations”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DERENOFYLLINE | Small molecule | 1.25 mg | Intravenous |
| Subject | DERENOFYLLINE | Small molecule | 3.75 mg | Intravenous |
| Subject | DERENOFYLLINE | Small molecule | 7.5 mg | Intravenous |
| Subject | DERENOFYLLINE | Small molecule | 15 mg | Intravenous |